Share on StockTwits

Cowen and Company upped their price objective on shares of UnitedHealth Group (NYSE:UNH) from $85.00 to $91.00 in a research note issued on Tuesday. Cowen and Company’s price target suggests a potential upside of 7.99% from the stock’s previous close.

A number of other analysts have also recently weighed in on UNH. Analysts at Susquehanna raised their price target on shares of UnitedHealth Group from $94.00 to $96.00 in a research note on Monday. Separately, analysts at Jefferies Group downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, July 10th. They now have a $87.00 price target on the stock. They noted that the move was a valuation call. Finally, analysts at Sterne Agee initiated coverage on shares of UnitedHealth Group in a research note on Friday, June 27th. They set an “underperform” rating and a $80.00 price target on the stock. Two analysts have rated the stock with a sell rating, six have assigned a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the company. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $81.95.

UnitedHealth Group (NYSE:UNH) traded up 0.51% on Tuesday, hitting $84.70. 594,969 shares of the company’s stock traded hands. UnitedHealth Group has a 52 week low of $65.92 and a 52 week high of $84.69. The stock has a 50-day moving average of $80.80 and a 200-day moving average of $77.32. The company has a market cap of $82.994 billion and a price-to-earnings ratio of 15.47.

UnitedHealth Group Incorporated (NYSE:UNH) diversified health and well-being company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.